Advertisement

Topics

Copernicus Group IRB Company Profile

22:20 EDT 22nd June 2018 | BioPortfolio

Copernicus Group IRB was established in July 1996 as an independent institutional review board (IRB or "Board") and operates in compliance with Federal Regulations governing institutional review boards set forth in 21 CFR, 45 CFR and ICH GCP Guidelines. Copernicus Group IRB is also a member of the Consortium of Independent Review Boards (CIRB), which regularly meets with government regulators to review issues of importance to the protection of human subjects involved in clinical research. Copernicus Group IRB has been inspected by the FDA and in July of 2004, Copernicus Group IRB was awarded full accreditation of our Human Research Protection Program by AAHRPP®, The Association for the Accreditation of Human Research Protection Programs, Inc. CGIRB is registered with OHRP as IRB00001313 which complies with all federal regulations pertaining to the protection of human research subjects

Location

118 MacKenan DriveSuite 400
Cary
North Carolina
27511
United States of America

Contact

Phone: (919) 465-4310
Fax: (919) 465-4311
Email: mafallon@cgirb.com


News Articles [401 Associated News Articles listed on BioPortfolio]

WCG (WIRB-Copernicus Group) Clinical Services Division Opens Office in Japan

WCG expands global clinical research support presence PRINCETON, New Jersey, May 22, 2018 /PRNewswire/ -- WCG™ (WIRB-Copernicus Group®) Clinical Services Division, ...

WIRB-Copernicus Group clinical services division acquires ACI Clinical

WCG Clinical Services Division expands portfolio to include specialist in endpoint adjudication and data monitoring safety committees

WCG Clinical Services Division expands portfolio through acquisition of ACI Clinical

Clinical services organisation, WIRB-Copernicus Group (WCG) Clinical Services Division, has expanded its portfolio through the acquisition of a provider of Endpoint Adjudication and Data Monitoring Sa...

Copernicus Plans Liberal Licensing for its Advanced DNA Delivery Technology

Imagine, for a moment, that every drug on the market suddenly didn’t work because of the lack of an adequate delivery system. That’s precisely the situation gene therapy companies find themselves ...

Copernicus Award 2018: Outstanding German-Polish cooperation in cardiology

(Deutsche Forschungsgemeinschaft) Cardiologists from Berlin and Wrocaw to receive the award from the DFG and the Foundation for Polish Science / Award ceremony to take place on October 25 in Berlin.

If We Discover Alien Life, Will Humanity Keep Its Cool?

For well over 1,500 years, humanity accepted that Earth was the center of the solar system. After all, the Bible—which was the scientific authority at the time—said this was so. Then along came N...

WCG Announces — Strategies that Inform Investigation Selection and Enhance Enrollment, Free Webinar, January 25, 2018

Clinical trial operators have no choice but to contract with sites. But are they optimizing the opportunity to accelerate study start-up, reduce expenses, and avoid complications? FALLS CHURCH, Va. (P...

Unlimited Group appoints group managing director

Michael Richards joins the group from VCCP

PubMed Articles [1806 Associated PubMed Articles listed on BioPortfolio]

Group Influences on Engaging Self-Control: Children Delay Gratification and Value It More When Their In-Group Delays and Their Out-Group Doesn't.

Self-control emerges in a rich sociocultural context. Do group norms around self-control influence the degree to which children use it? We tested this possibility by assigning 3- to 5-year-old childre...

An Examination of Group Size and Valence in Delay Discounting of Shared Outcomes.

Previous research has examined delay discounting in a group context, where the outcomes are shared with others. These studies indicate shallow delay discounting in a group context compared to an indiv...

Ameliorating effects of tempol on methotrexate-induced liver injury in rats.

Methotrexate (MTX) is used in the treatment of certain types of cancers and chronic inflammatory illnesses, although the clinical use of MTX is limited due to its adverse effects, the most common of w...

Medulloblastoma with transitional features between Group 3 and Group 4 is associated with good prognosis.

Medulloblastoma, the most common malignant pediatric brain tumor, is a heterogeneous disease, with the existence of at least four molecular types: Wingless (WNT), Sonic Hedgehog (SHH), Group 3 and Gro...

Nephroprotective Effect of Zingerone against CCl-Induced Renal Toxicity in Swiss Albino Mice: Molecular Mechanism.

The protective effects of Zingerone against CCl induced nephrotoxicity in Swiss albino mice via modulation of metabolizing enzyme, oxidative stress, inflammatory cytokines, and apoptosis. The biochemi...

Clinical Trials [3704 Associated Clinical Trials listed on BioPortfolio]

Ultra-wide Fluorescein Angiography in Patients With Central Retinal Vein Occlusion Treated by Afilbercept

In patients with macular edema secondary to CRVO, Aflibercept demonstrated efficacy and safety in 2 parallel trials, interventional phase III studies, COPERNICUS study performed in United ...

The Influence of Hypotensive Drugs on Mineral Status in Experimental and Clinical Studies

The aim of the study was to evaluate the effects of hypotensive treatment combined with a higher zinc supply in the diet and supplements on the mineral status and selected biochemical para...

Safety, Tolerability and Pharmacokinetics of Escalating Single Doses of TAK-828 in Healthy Participants

The purpose of this study is to evaluate the safety and tolerability of single oral doses of TAK-828 in healthy non-Japanese and Japanese participants.

Technical Development of Multi-Parametric Renocerebral MRI

The purpose of the study is to investigate the associations of the age-related changes in the brain, kidneys and cognitive performance in healthy adults by utilizing multiple anatomic and ...

Electro-acupuncture and Flumazenil's Effect on Sedation

Object: To explore the mechanism of the electro-acupuncture (EA) induced sedation effect in general anaesthesia through investigating the role of the Benzodiazepines-GABA system. Method: ...

Companies [1618 Associated Companies listed on BioPortfolio]

Copernicus Group IRB

Copernicus Group IRB was established in July 1996 as an independent institutional review board (IRB or "Board") and operates in compliance with Federal Regulations governing institutional review board...

Copernicus Therapeutics Incorporated

Copernicus Therapeutics, Inc. is a privately-held company developing products for human gene therapy and vaccination. Copernicus was established in 1997 based on technologies discovered at Case Wester...

Copernicus Therapeutics, Inc.

Copernicus' Management and Board of Directors have experience in company management, pharmaceutical/biotechnology R&D, clinical development, and finance.

W2 Group, Inc.

W2 Group is a global marketing services ecosystem that helps CMOs in their new role as builders of communities and content aggregators. W2 Group companies, including Digital ...

PharmEvo (Pvt.) Ltd.

PharmEvo is backed by a reputable corporate group with a history of successful business ventures spread over 30 years. The group made its debut in 1971, with the sales and marketing of prestigious bra...

More Information about "Copernicus Group IRB" on BioPortfolio

We have published hundreds of Copernicus Group IRB news stories on BioPortfolio along with dozens of Copernicus Group IRB Clinical Trials and PubMed Articles about Copernicus Group IRB for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Copernicus Group IRB Companies in our database. You can also find out about relevant Copernicus Group IRB Drugs and Medications on this site too.

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks



Searches Linking to this Company Record